Cancer pts w/inherited thrombophilias have increased risk of Venous Thromboembolism. In this systematic review & meta-analysis, non-O blood type, Factor V Leiden & Prothrombin G20210A mutations were found to be important risk factors for cancer-assoc VTE.
https://t.co/no6GsZZHyE
#PublicationThursday🧵1/2
The objective of this #PostHocAnalysis was to determine the influence of inherited #Thrombophilia on VTE & bleeding risk in moderate-to-high-risk ambulatory cancer patients receiving #Chemotherapy. Find the results published by @daniellle_roy,
Inherited thrombophilia can 📈risk of cancer-associated thrombosis.
@daniellle_roy et al @UottawamedG@OttawaHospital found patients with FVLeiden mutation & non-🅾️🩸blood types
▶️📈#cancer-associated #thrombosis
https://t.co/OT6ZWv42Xw
Abstract #2517: "Blood Biomarkers for the Prediction of Venous Thromboembolism in Perioperative or Hospitalized Cancer Patients: A Systematic Review" in session 332 - @TzufeiWang@PhilWellsMD1 @daniellle_roy
https://t.co/vukFCCRenF
#CanVECTORatASH2022#VTE#Research
In patients with minor ischemic stroke/TIA, study found dual antiplatelet therapy with aspirin and either ticagrelor or clopidogrel was effective in preventing strokes/death. https://t.co/ke7ZtEJeI3 @rondalun1 @GZitikyte @BH_epistat
Check out this interview from @NeurologyToday on our recently published NMA on the use of DAPT in minor ischemic stroke/ TIA! @GZitikyte @BH_epistat @daniellle_roy @JAMANeuro
In patients with minor ischemic stroke/TIA, study found dual antiplatelet therapy with aspirin and either ticagrelor or clopidogrel was effective in preventing strokes/death https://t.co/zalLQwRhac @rondalun1 @GZitikyte @BH_epistat
Beyond ecstatic to announce our network meta-analysis was published today in @JAMANeuro! "Ticagrelor vs Clopidogrel With Aspirin in Minor Ischemic Stroke and Transient Ischemic Attack" https://t.co/gkO2sheMMj via @JAMANetwork @GZitikyte @daniellle_roy @BH_epistat@uOttawa_SEPH